Wagner, K; Springer, B; Pires, V P; Keller, P M (2019). High-throughput screening of bacterial pathogens in clinical specimens using 16S rDNA qPCR and fragment analysis. Diagnostic Microbiology and Infectious Disease, 93(4):287-292.
Wagner, K; Imkamp, F; Pires, V P; Keller, P M (2019). Evaluation of Lightmix Mycoplasma macrolide assay for detection of macrolide-resistant Mycoplasma pneumoniae in pneumonia patients. Clinical Microbiology and Infection, 25(3):383.e5-383.e7.
Wagner, K; Springer, B; Pires, V P; Keller, P M (2018). Molecular detection of fungal pathogens in clinical specimens by 18S rDNA high-throughput screening in comparison to ITS PCR and culture. Scientific Reports, 8:6964.
Egli, A; Blanc, D; Greub, G; Keller, P; Lazarevic, V; Lebrand, A; Leib, S; Neher, R; Perreten, V; Ramette, A; Schrenzel, J; Stephan, R; Wagner, K; Wüthrich, D; Xenarios, I (2018). Bacterial genome sequencing and analysis: paving the way for a Swiss-wide molecular epidemiological surveillance platform. Swiss Medical Weekly, 148:w14693.
Ryan, P; Wagner, K; Teuber, S; Backes-Gellner, U (2010). Corporate ownership and initial training in Britain, Germany and Switzerland. Swiss Leading House Working Paper 55, University of Zurich.
Ryan, P; Wagner, K; Teuber, S; Backes-Gellner, U (2010). Trainee pay in Britain, Germany and Switzerland: markets and institutions. SKOPE Research Paper 96, Shool of Social Sciences, Cardiff University.
Haag, A; Knake, S; Hamer, H M; Boesebeck, F; Freitag, H; Schulz, R; Baum, P; Helmstaedter, C; Wellmer, J; Urbach, H; Hopp, P; Mayer, T; Hufnagel, A; Jokeit, H; Lerche, H; Uttner, I; Meencke, H J; Meierkord, H; Pauli, E; Runge, U; Saar, J; Trinka, E; Benke, T; Vulliemoz, S; Wiegand, G; Stephani, U; Wieser, H G; Rating, D; Werhahn, K; Noachtar, S; Schulze-Bonhage, A; Wagner, K; Alpherts, W C J; van Emde Boas, W; Rosenow, F (2008). The Wada test in Austrian, Dutch, German, and Swiss epilepsy centers from 2000 to 2005: a review of 1421 procedures. Epilepsy & Behavior : E&B, 13(1):83-89.
Ruschitzka, F T; Wenger, R H; Stallmach, T; Quaschning, T; de Wit, C; Wagner, K; Labugger, R; Kelm, M; Noll, G; Rülicke, T; Shaw, S; Lindberg, R L; Rodenwaldt, B; Lutz, H; Bauer, C; Lüscher, T F; Gassmann, M (2000). Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 97(21):11609-11613.